Bacterial cell surface biological response modifiers and their synthetic counterparts.
Kotani
S
S
Osaka College of Medical Technology, Japan.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000276:immunology; D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D001419:Bacteria / Q000276:immunology*; D002240:Carbohydrate Sequence; D016207:Cytokines / Q000096:biosynthesis; D006168:Guinea Pigs; D007155:Immunologic Factors / Q000737:chemistry / Q000276:immunology* / Q000494:pharmacology; D007252:Influenza Vaccines / Q000008:administration & dosage; D008050:Lipid A / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000276:immunology; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008969:Molecular Sequence Data; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D010963:Plasmodium falciparum / Q000276:immunology; D013682:Teichoic Acids / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D016207:Cytokines; D007155:Immunologic Factors; D007252:Influenza Vaccines; D008050:Lipid A; D008070:Lipopolysaccharides; D013682:Teichoic Acids; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C009900:lipoteichoic acid; C044706:B 30-muramyl dipeptide